Found: 13
Select item for more details and to access through your institution.
Standard Versus Reduced CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: An Observational Multicenter Study.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 23, p. 7441, doi. 10.3390/jcm13237441
- By:
- Publication type:
- Article
The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy among Patients with Urothelial Carcinoma: A Meta-Analysis.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 5, p. 842, doi. 10.3390/jpm12050842
- By:
- Publication type:
- Article
Manumycin inhibits farnesyltransferase and induces apoptosis of drug-resistant interleukin 6-producing myeloma cells.
- Published in:
- British Journal of Haematology, 2002, v. 118, n. 1, p. 157, doi. 10.1046/j.1365-2141.2002.03559.x
- By:
- Publication type:
- Article
Systemic Treatments for Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Old Certainties and New Frontiers.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2022, v. 29, p. 1, doi. 10.1177/10732748221106267
- By:
- Publication type:
- Article
Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study.
- Published in:
- Cancers, 2024, v. 16, n. 20, p. 3442, doi. 10.3390/cancers16203442
- By:
- Publication type:
- Article
Compassionate Use Program of Ipilimumab and Nivolumab in Intermediate or Poor Risk Metastatic Renal Cell Carcinoma: A Large Multicenter Italian Study.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092293
- By:
- Publication type:
- Article
Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1404, doi. 10.3390/cancers14061404
- By:
- Publication type:
- Article
Systemic Treatments for Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Old Certainties and New Frontiers.
- Published in:
- 2022
- By:
- Publication type:
- Book Review
Current and Future Role of Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: Which Way to Go Forward.
- Published in:
- Medicina (1010660X), 2022, v. 58, n. 5, p. 600, doi. 10.3390/medicina58050600
- By:
- Publication type:
- Article
Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress.
- Published in:
- Current Oncology, 2022, v. 29, n. 10, p. 7925, doi. 10.3390/curroncol29100626
- By:
- Publication type:
- Article
Systemic Treatment for Metastatic Biliary Tract Cancer: State of the Art and a Glimpse to the Future.
- Published in:
- Current Oncology, 2022, v. 29, n. 2, p. 551, doi. 10.3390/curroncol29020050
- By:
- Publication type:
- Article
Pathological Complete Response to Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: An Updated Meta-Analysis.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 12, p. 1857, doi. 10.3390/cells11121857
- By:
- Publication type:
- Article
Synergizing Immunotherapy and Antibody–Drug Conjugates: New Horizons in Breast Cancer Therapy.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 9, p. 1146, doi. 10.3390/pharmaceutics16091146
- By:
- Publication type:
- Article